TX: DWC Rule Addresses Compounded Drugs


Austin, TX (WorkersCompensation.com) - When a Texas House committee asked the Division of Workers’ Compensation to look at compounded drug prescriptions for injured employees, the division turned to its data on pharmacy billing and an ongoing audit of doctors’ practices for answers. It found that the cost of compounded drugs doubled from 2010-2014, and the average cost per prescription had risen to $829 in 2016.

The numbers were concerning because compounded drugs aren’t recommended as first line medications in treatment guidelines for injured employees. After getting DWC’s report, members of the House Committee on Business & Industry asked DWC to address the issues through a new rule.  DWC adopted a new rule on March 29, 2018 requiring compounded drugs to be preauthorized and will be applicable statewide beginning July 1, 2018.

“We were looking to DWC to develop a rule that maintains access to these drugs but helps prevent fraud and unnecessary use,” said Chairman Rene Oliveira. “And we’ve encouraged DWC to get input from carriers, doctors, patients, pharmacists, and other stakeholders throughout that process.”

Compounded drugs are not FDA-approved and the FDA does not verify their safety, effectiveness, or quality. The FDA has found that the labeling of compounded drugs often omits important information and that poor compounding practices can result in serious drug quality problems, such as contamination or medications that do not possess the strength, quality, and purity they are supposed to have. Additionally, the FDA has reported its concern that some compounders produce drugs for patients even though an FDA-approved drug may have been medically appropriate for them.

 “We want to make sure the use of these drugs is being reviewed and that physicians are considering efficacy and appropriateness of alternatives while still ensuring that patients who need compounded drugs will still be able to get them,” says Matt Zurek, deputy commissioner for Health and Safety.

Concerns about compounded drugs aren’t unique to the Texas workers’ compensation system. In 2014, the Employee Retirement System of Texas began requiring preauthorization for all compounded drugs costing $300 or more. The change reduced ERS expenditures on those drugs from $35.7 million in Fiscal Year 2014 to $1.2 million in Fiscal Year 2015. In January, ERS tightened the requirements even more, requiring preauthorization for compounded drugs costing more than $50.

Looking at the issue

A May 2017 report by DWC’s Research and Evaluation group found that:

  • The number of compounded drugs increased from 18,020 prescriptions in 2010 to 26,380 in 2014.
  • The total cost of compounded drugs increased from $6 million in 2010 to $12 million in 2014.
  • The average cost per compounded drug prescription increased from $356 in 2010 to $829 in 2016.
  • Almost a third of compounded drug prescriptions were to treat back injuries.

Read More

Request a Demo

To request a free demo of one of our products, please fill in this form. Our sales team will get back to you shortly.